Is Cognition Therapeutics, Inc. (CGTX) a Buy, Sell, or Hold?
Cognition Therapeutics, Inc.
NASDAQ:CGTX
$0.9491 USD
-$0.06 (-6.03%)
- Volume
- 1.36M
- Average Volume
- 1.57M
- Market Capitalization
- $69.84M
- P/E Ratio
- -3.62
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $3.83
- Year Low
- $0.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.92
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
16
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
13
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 266.57K
CGTX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CGTX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Khattar Jack A. | director | 2026-06-17 | A-Award | 0 | 2026-06-22 |
| Monia Brett P | director | 2026-06-17 | A-Award | 0 | 2026-06-22 |
| Wallace Peggy | director | 2026-06-17 | A-Award | 0 | 2026-06-22 |
| RICHSTONE ELLEN B | director | 2026-06-17 | A-Award | 0 | 2026-06-22 |
| Fletcher Aaron G.L. | director, 10 percent owner: | 2026-06-17 | A-Award | 0 | 2026-06-22 |
| Doyle John Brendan | officer: Chief Financial Officer | 2026-05-01 | F-InKind | 1.28 | 2026-05-04 |
| Doyle John Brendan | officer: Chief Financial Officer | 2026-04-16 | P-Purchase | 1.13 | 2026-04-20 |
| Ricciardi Lisa | director, officer: CEO & President | 2026-04-16 | P-Purchase | 1.1 | 2026-04-20 |
| Caggiano Anthony | officer: Chief Medical Officer | 2026-04-16 | P-Purchase | 1.11 | 2026-04-20 |
| Ricciardi Lisa | director, officer: CEO & President | 2026-02-15 | F-InKind | 1.12 | 2026-02-18 |
| Doyle John Brendan | officer: Chief Financial Officer | 2026-02-15 | F-InKind | 1.12 | 2026-02-18 |
| Caggiano Anthony | officer: Chief Medical Officer | 2026-02-15 | F-InKind | 1.12 | 2026-02-18 |
| Ricciardi Lisa | director, officer: CEO & President | 2026-02-03 | A-Award | 0 | 2026-02-05 |
| Ricciardi Lisa | director, officer: CEO & President | 2026-02-03 | F-InKind | 1.12 | 2026-02-05 |
| Ricciardi Lisa | director, officer: CEO & President | 2026-02-04 | F-InKind | 1.03 | 2026-02-05 |
| Doyle John Brendan | officer: Chief Financial Officer | 2026-02-03 | A-Award | 0 | 2026-02-05 |
| Doyle John Brendan | officer: Chief Financial Officer | 2026-02-04 | F-InKind | 1.03 | 2026-02-05 |
| Caggiano Anthony | officer: Chief Medical Officer | 2026-02-03 | A-Award | 0 | 2026-02-05 |
| Caggiano Anthony | officer: Chief Medical Officer | 2026-02-03 | F-InKind | 1.12 | 2026-02-05 |
| Caggiano Anthony | officer: Chief Medical Officer | 2026-02-04 | F-InKind | 1.03 | 2026-02-05 |
| Ricciardi Lisa | director, officer: CEO & President | 2025-12-18 | A-Award | 0 | 2025-12-22 |
| Ricciardi Lisa | director, officer: CEO & President | 2025-12-18 | F-InKind | 1.5 | 2025-12-22 |
| Caggiano Anthony | officer: Chief Medical Officer | 2025-12-18 | A-Award | 0 | 2025-12-22 |
| Caggiano Anthony | officer: Chief Medical Officer | 2025-12-18 | F-InKind | 1.5 | 2025-12-22 |
| Doyle John Brendan | officer: Chief Financial Officer | 2025-12-18 | A-Award | 0 | 2025-12-22 |
| Doyle John Brendan | officer: Chief Financial Officer | 2025-12-18 | F-InKind | 1.5 | 2025-12-22 |
| Fletcher Aaron G.L. | director, 10 percent owner: | 2025-09-19 | M-Exempt | 0.84 | 2025-09-23 |
| Fletcher Aaron G.L. | director, 10 percent owner: | 2025-09-19 | M-Exempt | 0.84 | 2025-09-23 |
| Caggiano Anthony | officer: Chief Medical Officer | 2025-07-29 | A-Award | 0 | 2025-07-31 |
| Caggiano Anthony | officer: Chief Medical Officer | 2025-07-29 | F-InKind | 0.6702 | 2025-07-31 |
| Doyle John Brendan | officer: Chief Financial Officer | 2025-07-29 | A-Award | 0 | 2025-07-31 |
| Doyle John Brendan | officer: Chief Financial Officer | 2025-07-29 | F-InKind | 0.6702 | 2025-07-31 |
| Ricciardi Lisa | director, officer: CEO & President | 2025-07-29 | A-Award | 0 | 2025-07-31 |
| Ricciardi Lisa | director, officer: CEO & President | 2025-07-29 | F-InKind | 0.6702 | 2025-07-31 |
| Khattar Jack A. | director | 2025-06-18 | A-Award | 0 | 2025-06-23 |
| Wallace Peggy | director | 2025-06-18 | A-Award | 0 | 2025-06-23 |
| RICHSTONE ELLEN B | director | 2025-06-18 | A-Award | 0 | 2025-06-23 |
| Monia Brett P | director | 2025-06-18 | A-Award | 0 | 2025-06-23 |
| Kreis Leslie W. | director, 10 percent owner: | 2025-06-18 | A-Award | 0 | 2025-06-20 |
| Fletcher Aaron G.L. | director, 10 percent owner: | 2025-06-18 | A-Award | 0 | 2025-06-20 |
| Doyle John Brendan | officer: Chief Financial Officer | 2025-05-01 | F-InKind | 0.4472 | 2025-05-02 |
| Ricciardi Lisa | director, officer: CEO & President | 2025-02-15 | F-InKind | 0.5901 | 2025-02-18 |
| Caggiano Anthony | officer: Chief Medical Officer | 2025-02-15 | F-InKind | 0.5901 | 2025-02-18 |
| Doyle John Brendan | officer: Chief Financial Officer | 2025-02-15 | F-InKind | 0.5901 | 2025-02-18 |
| Caggiano Anthony | officer: Chief Medical Officer | 2025-02-04 | A-Award | 0 | 2025-02-04 |
| Caggiano Anthony | officer: Chief Medical Officer | 2025-02-03 | F-InKind | 0.666 | 2025-02-04 |
| Doyle John Brendan | officer: Chief Financial Officer | 2025-02-04 | A-Award | 0 | 2025-02-04 |
| Ricciardi Lisa | director, officer: CEO & President | 2025-02-04 | A-Award | 0 | 2025-02-04 |
| Ricciardi Lisa | director, officer: CEO & President | 2025-02-03 | F-InKind | 0.666 | 2025-02-04 |
| Ricciardi Lisa | director, officer: CEO & President | 2025-01-31 | P-Purchase | 0.7722 | 2025-02-04 |
| Kreis Leslie W. | director, 10 percent owner: | 2024-06-07 | A-Award | 0 | 2024-06-11 |
| Kreis Leslie W. | director, 10 percent owner: | 2024-06-07 | A-Award | 1.95 | 2024-06-11 |
| Fletcher Aaron G.L. | director, 10 percent owner: | 2024-06-07 | A-Award | 0 | 2024-06-11 |
| Fletcher Aaron G.L. | director, 10 percent owner: | 2024-06-07 | A-Award | 1.95 | 2024-06-11 |
| Wallace Peggy | director | 2024-06-07 | A-Award | 0 | 2024-06-11 |
| Wallace Peggy | director | 2024-06-07 | A-Award | 1.95 | 2024-06-11 |
| Khattar Jack A. | director | 2024-06-07 | A-Award | 0 | 2024-06-11 |
| Khattar Jack A. | director | 2024-06-07 | A-Award | 1.95 | 2024-06-11 |
| RICHSTONE ELLEN B | director | 2024-06-07 | A-Award | 0 | 2024-06-11 |
| RICHSTONE ELLEN B | director | 2024-06-07 | A-Award | 1.95 | 2024-06-11 |
| Monia Brett P | director | 2024-06-07 | A-Award | 0 | 2024-06-11 |
| Monia Brett P | director | 2024-06-07 | A-Award | 1.95 | 2024-06-11 |
| Doyle John Brendan | officer: Chief Financial Officer | 2024-05-01 | F-InKind | 1.95 | 2024-05-03 |
| Ricciardi Lisa | director, officer: CEO & President | 2024-03-14 | P-Purchase | 1.75 | 2024-03-14 |
| Doyle John Brendan | officer: Chief Financial Officer | 2024-02-15 | A-Award | 0 | 2024-02-20 |
| Doyle John Brendan | officer: Chief Financial Officer | 2024-02-15 | A-Award | 1.98 | 2024-02-20 |
| Caggiano Anthony | officer: Chief Medical Officer | 2024-02-15 | A-Award | 0 | 2024-02-20 |
| Caggiano Anthony | officer: Chief Medical Officer | 2024-02-15 | A-Award | 1.98 | 2024-02-20 |
| Ricciardi Lisa | director, officer: CEO & President | 2024-02-15 | A-Award | 0 | 2024-02-20 |
| Ricciardi Lisa | director, officer: CEO & President | 2024-02-15 | A-Award | 1.98 | 2024-02-20 |
| Caggiano Anthony | officer: Chief Medical Officer | 2024-02-03 | F-InKind | 2.29 | 2024-02-09 |
| Ricciardi Lisa | director, officer: CEO & President | 2024-02-03 | F-InKind | 2.29 | 2024-02-09 |
| Bios Clinical Opportunity Fund, LP | director, 10 percent owner: | 2023-11-08 | 0 | 2023-11-13 | |
| Kreis Leslie W. | director, 10 percent owner: | 2023-11-08 | A-Award | 1.05 | 2023-11-13 |
| Fletcher Aaron G.L. | director, 10 percent owner: | 2023-11-08 | A-Award | 1.05 | 2023-11-13 |
| Kreis Leslie W. | director, 10 percent owner: | 2023-06-09 | A-Award | 2.77 | 2023-06-13 |
| Kreis Leslie W. | director, 10 percent owner: | 2023-06-09 | A-Award | 0 | 2023-06-13 |
| Fletcher Aaron G.L. | director, 10 percent owner: | 2023-06-09 | A-Award | 2.77 | 2023-06-13 |
| Fletcher Aaron G.L. | director, 10 percent owner: | 2023-06-09 | A-Award | 0 | 2023-06-13 |
| Monia Brett P | director | 2023-06-09 | A-Award | 2.77 | 2023-06-13 |
| Monia Brett P | director | 2023-06-09 | A-Award | 0 | 2023-06-13 |
| Wallace Peggy | director | 2023-06-09 | A-Award | 0 | 2023-06-13 |
| Wallace Peggy | director | 2023-06-09 | A-Award | 2.77 | 2023-06-13 |
| RICHSTONE ELLEN B | director | 2023-06-09 | A-Award | 0 | 2023-06-13 |
| RICHSTONE ELLEN B | director | 2023-06-09 | A-Award | 2.77 | 2023-06-13 |
| Khattar Jack A. | director | 2023-06-09 | A-Award | 0 | 2023-06-13 |
| Khattar Jack A. | director | 2023-06-09 | A-Award | 2.77 | 2023-06-13 |
| Doyle John Brendan | officer: Chief Financial Officer | 2023-05-01 | A-Award | 1.65 | 2023-05-03 |
| Doyle John Brendan | officer: Chief Financial Officer | 2023-05-01 | A-Award | 0 | 2023-05-03 |
| Doyle John Brendan | officer | 2023-05-01 | 0 | 2023-05-03 | |
| Caggiano Anthony | officer: Chief Medical Officer | 2023-02-03 | A-Award | 0 | 2023-02-07 |
| Caggiano Anthony | officer: Chief Medical Officer | 2023-02-03 | A-Award | 2.12 | 2023-02-07 |
| Ricciardi Lisa | director, officer: CEO & President | 2023-02-03 | A-Award | 0 | 2023-02-07 |
| Ricciardi Lisa | director, officer: CEO & President | 2023-02-03 | A-Award | 2.12 | 2023-02-07 |
| RICHSTONE ELLEN B | director | 2022-11-29 | P-Purchase | 2.655 | 2022-11-29 |
| Fletcher Aaron G.L. | director | 2022-11-28 | P-Purchase | 2.6497 | 2022-11-29 |
| Fletcher Aaron G.L. | director | 2022-11-28 | P-Purchase | 2.6497 | 2022-11-29 |
| Fletcher Aaron G.L. | director | 2022-11-28 | P-Purchase | 2.6497 | 2022-11-29 |
| Kreis Leslie W. | director | 2022-11-28 | P-Purchase | 2.6497 | 2022-11-29 |
| Kreis Leslie W. | director | 2022-11-28 | P-Purchase | 2.6497 | 2022-11-29 |